Job:Principal Scientist - Computational Biology (209108)
0
0
Entering edit mode
3.7 years ago

OUR COMPANY

At Boehringer Ingelheim we develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We believe that, if we have talented and ambitious people who are passionate about innovation, there is no limit to what we can achieve; after all, we started with just 28 people. Now, we are powered by 50,000 employees globally who nurture a diverse, collaborative and inclusive culture.

THE POSITION

A lot to do despite Corona! Boehringer Ingelheim is still looking for new colleagues!

Take advantage of your experience; employ digital innovation to actively boost the discovery and development of new medicines to assure sustainable growth of a globally leading and family-owned pharmaceutical company.

As a Principal Scientist Computational Biology you identify novel putative targets by cutting edge in silico analyses, strengthen new therapeutic concepts and identify biomarkers in the area of cardiometabolic diseases (e.g. retinopathies, NASH, obesity), using leading edge computational methods to drive faster, improved decision making, ultimately developing impactful therapies for our patients. You like the challenge of building a convincing line of reasoning to go from in-silico predictions to experimental validation. In addition, you are passionate for drug discovery, experienced in implementing disruptive ideas into an organization and take advantage of data-driven digital innovation.

Embedded in BI’s growing Global Computational Biology and Digital Sciences Unit you will have an impact on reinventing R&D, thereby actively contributing to the discovery of breakthrough therapies that ultimately will improve the quality of human life.

Tasks & responsibilities

  • Together with the therapeutic area, you will conceive and direct the implementation of data-driven solutions to support target identification, target-driven research and presentation of results to your stakeholders and the TA and GCBDS management board.
  • In your new role, you work with data from multiple domains, such as transcriptomics (RNAseq, scRNAseq) or genetics using established and innovative methods.
  • You contribute to projects during all phases - from experimental design to downstream analysis in interdisciplinary teams.
  • Furthermore, you establish and develop new analysis strategies in the field of omics data, network biology and machine learning aiming to push boundaries in drug discovery.

Requirements

  • PhD in bioinformatics, computational biology or systems biology research or similar with strong quantitative focus and excellent programming skills. Alternatively master’s degree with long-term professional experience
  • In-depth knowledge and broad spectrum in bioinformatics and computational biology with a focus on omics data
  • Deep knowledge in R/Bioconductor (preferred) or Python and solid background in statistics and experimental design
  • Previous projects in cardiometabolic indications are desirable
  • Highly motivated Team player with excellent organization and communication skills
  • Fluency in English writing and speaking

EFFECTS OF COVID-19

We will continue to hire talented people and we look forward to receiving your applications. As a result of COVID-19, we have introduced alternative working arrangements to ensure that our employees can stay safe and healthy, because the health of our employees is among our top priorities. At all company locations, we work remotely whenever possible. Additionally, we are now hosting virtual video interviews for applicants. During the limited in-person interviews we still have during this time, we pay special attention to distance and the hygiene rules recommended by the Robert Koch Institute. New employees who do not start on site in production or the laboratories are sent the necessary IT equipment, our Welcome Days take place online, and we plan to conduct their onboarding training virtually whenever possible.

WHY BOEHRINGER INGELHEIM?

This is where you can grow, collaborate, innovate and improve lives.

We offer challenging work in a respectful and friendly global working environment surrounded by a world of innovation driven mindsets and practices. In addition, learning and development for all employees is key, because your growth is our growth. We also offer a competitive salary, generous amount of vacation time, and numerous benefits towards your wellness & financial health and work-life balance. Plus, an onsite gym (Ingelheim), in-house doctor and best-in-class cafeterias and coffee bars to keep you energized and healthy. To learn more about what benefits could be waiting for you, please visit our Career area.

Want to learn more about us? Visit https://www.boehringer-ingelheim.com/

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment, which benefits our employees, patients and communities. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity or national origin.

READY TO CONTACT US?

Please contact our Recruiting EMEA Team: Artur Reich, Tel: +49 (7351) 54-175904

Not exactly the position you are looking for but have someone else in mind? Share it via the button on the bottom of the page with friends or colleagues who might be interested.

Job - Research & Development

Primary Location - Biberach an der Riss (Germany)

Organization - Boehringer Ingelheim Pharma GmbH&Co.KG

Schedule - Full-time

Apply now: https://tas-boehringer.taleo.net/careersection/global+template+career+section+28external29/jobdetail.ftl?job=209108&tz=GMT%2B02%3A00&tzname=Europe%2FBerlin

gene RNA-Seq • 1.4k views
ADD COMMENT

Login before adding your answer.

Traffic: 2457 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6